The BCL-2 Family Protein Inhibitor, ABT-737, Has Substantial Antimyeloma Activity and Shows Synergistic Effect With Dexamethasone and Melphalan
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-06-1526
Full Text
Open PDFAbstract
Available in full text
Date
January 15, 2007
Authors
Publisher
American Association for Cancer Research (AACR)